Category:

Abbott Laboratories won U.S. approval for its molecular test for the Coronavirus strain COVID-19, which will be used by hospitals and academic medical centers to speed diagnostic capabilities...The “emergency use authorization” from the U.S. Food and Drug Administration allows Abbott to begin shipping 150,000 laboratory tests immediately, the company said Wednesday. The tests are run on Abbott’s “m2000TM RealTime System,” which is already located in more than 175 U.S hospitals and academic medical centers...Abbott said the company will begin scaling up production at its U.S. manufacturing plant “to reach capacity for 1 million tests per week by end of March.” Abbott said its systems have “the ability to run high volumes of up to 470 tests in 24 hours, helping to meet the increasing demand for testing.”...READ MORE

As the spread of COVID-19 threatens to disrupt pharma supply chains and create drug shortages, the Trump administration is reportedly looking for ways to reduce U.S. dependence on APIs and drugs from China. So, how dependent is the U.S. on China for its drugs? The fact is, the FDA doesn’t know...“The FDA doesn’t know whether Chinese facilities are actually producing APIs, how much they are producing, or where the APIs they are producing are being distributed worldwide, including in the United States,...Similarly, we do not have information that would enable us to assess the resilience of the U.S. manufacturing base, should it be tested by China’s withdrawal from supplying the U.S. market.”...READ MORE

Three major spring meetings for pharmacists have been cancelled due to the coronavirus...

• APhA...to cancel its APhA 2020 Meeting and Exhibition...March 20-23
• NACDS was...forced to cancel its 12th Annual NACDS RxIMPACT Day on Capitol Hill...planned for March 10 to 11
• The American College of Clinical Pharmacy...cancelled its 2020 ACCP Spring Forum...held in St. Louis, Miss., April 25 to 26

Florida Governor Ron DeSantis signed a bill into law allowing pharmacists to test and initiate treatment for influenza and Group A Streptococcus...“The bill will improve convenient access to quality care while removing avoidable pressures on hospitals and acute settings–a meaningful benefit at all times, and a benefit that is top-of-mind amid demanding public health situations ranging from flu outbreaks to the current coronavirus concerns...READ MORE

Sisolak announced during a press conference in Las Vegas that he had signed the emergency declaration, which included activating a State Emergency Operation Center and emergency team to centralize response to the virus, loosening regulations for government agencies to purchase food and other supplies, creation of a website with centralized information and reinforced the attorney general’s office’s ability to enforce consumer protection laws...“At this time it has become clear that this extra step is necessary in order to meet the goal, to ensure that the public health and safety of our citizens and to ensure that we have the resources at our disposal to immediately and aggressively respond,” Sisolak said...READ MORE

Gov. Steve Sisolak said that while a testing kit shortage makes it impossible to tell how much coronavirus has affected Nevada, the pace of the virus’ spread around the world means Nevada must “act quickly” to slow it — including taking drastic measures such as shutting state offices, limiting the size of gatherings and encouraging employees to work from home if possible...the governor asked local governments to enforce a new Centers for Disease Control and Prevention guideline that all events with attendance above 50 be canceled or postponed for the next eight weeks...READ MORE

Trump also announced a range of executive actions, including a new public-private partnership to expand coronavirus testing capabilities with drive-through locations, as Washington tries to subdue the new virus whose spread is roiling markets, shuttering institutions and disrupting the lives of everyday Americans...READ MORE

Legislation recently introduced in the US House of Representatives will help curb drug shortages, particularly in light of potential COVID-19 supply chain issues...The Preventing Drug Shortages Act (H.R. 6080) was introduced by a group of Congressional representatives...It would help mitigate shortage triggers by enhancing transparency throughout the drug supply chain process and strengthening FDA interagency efforts to fend off drug shortages...READ MORE

The Trump administration has issued blanket waivers and new flexibilities to help hospitals and facilities cope with the coronavirus outbreak...“It is vital that federal requirements designed for periods of relative calm do not hinder measures needed in an emergency,” CMS Administrator Seema Verma said in a statement. “The nationwide waivers we are activating today will be a godsend for those on the frontlines of the fight against this new virus.”...Some of the waivers and flexibilities that CMS took on Friday include:

• Waiving requirements that critical access hospitals limit the number of beds to 25 and length of stay to 96 hours;
• Enabling acute care hospitals to house acute care patients in a separate unit;
• Waiving replacement requirements when durable medical equipment gets damaged or unusable. A contractor can waive requirements such as a new physician’s order, face-to-face requirement and other documentation; and
• Allowing long-term care hospitals to exclude patients stays from the 25-day average length requirement if treatment is required in conjunction with the emergency.
• CMS also sought to quickly approve waivers for states and territories for Medicare, Medicaid and the Children’s Health Insurance Program...READ MORE

Christina Mattina, welcome to This Week in Managed Care from the Managed Markets News Network